Corporate Governance25 Sept 2026, 02:12 pm
Marksans Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Marksans Pharma Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. The specific date for the financial results announcement will be communicated separately. During this period, no trading in the company's shares is permitted for these individuals.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from October 1, 2026.
- Period extends until 48 hours post-results declaration.
- Unaudited results for Q2 FY27 are pending.
- No trading allowed during the closure period.
Price Impact
More from MARKSANS